全文获取类型
收费全文 | 4439篇 |
免费 | 209篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 85篇 |
妇产科学 | 183篇 |
基础医学 | 666篇 |
口腔科学 | 59篇 |
临床医学 | 460篇 |
内科学 | 1117篇 |
皮肤病学 | 52篇 |
神经病学 | 381篇 |
特种医学 | 159篇 |
外科学 | 550篇 |
综合类 | 21篇 |
一般理论 | 2篇 |
预防医学 | 203篇 |
眼科学 | 30篇 |
药学 | 317篇 |
中国医学 | 3篇 |
肿瘤学 | 354篇 |
出版年
2023年 | 20篇 |
2022年 | 50篇 |
2021年 | 89篇 |
2020年 | 51篇 |
2019年 | 71篇 |
2018年 | 97篇 |
2017年 | 86篇 |
2016年 | 73篇 |
2015年 | 90篇 |
2014年 | 114篇 |
2013年 | 179篇 |
2012年 | 327篇 |
2011年 | 368篇 |
2010年 | 186篇 |
2009年 | 156篇 |
2008年 | 327篇 |
2007年 | 353篇 |
2006年 | 289篇 |
2005年 | 299篇 |
2004年 | 319篇 |
2003年 | 294篇 |
2002年 | 244篇 |
2001年 | 34篇 |
2000年 | 27篇 |
1999年 | 48篇 |
1998年 | 72篇 |
1997年 | 46篇 |
1996年 | 52篇 |
1995年 | 52篇 |
1994年 | 24篇 |
1993年 | 18篇 |
1992年 | 26篇 |
1991年 | 26篇 |
1990年 | 19篇 |
1989年 | 16篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 16篇 |
1985年 | 15篇 |
1984年 | 11篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 12篇 |
1980年 | 3篇 |
1978年 | 7篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1969年 | 3篇 |
1965年 | 4篇 |
排序方式: 共有4686条查询结果,搜索用时 66 毫秒
61.
Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. 总被引:9,自引:0,他引:9
Christophe van de Wiele Christophe Lahorte Hubert Vermeersch D Loose Kris Mervillie Neil D Steinmetz Jean-Luc Vanderheyden Claude A Cuvelier Guido Slegers Rudi A Dierck 《Journal of clinical oncology》2003,21(18):3483-3487
PURPOSE: Radiolabeled annexin V may allow for repetitive and selective in vivo identification of apoptotic cell death without the need for invasive biopsy. This study reports on the relationship between quantitative technetium-99m- (99mTc-) 6-hydrazinonicotinic (HYNIC) radiolabeled annexin V tumor uptake, and the number of tumor apoptotic cells derived from histologic analysis. PATIENTS AND METHODS: Twenty patients (18 men, two women) suspected of primary (n = 19) or recurrent (n = 1) head and neck carcinoma were included. All patients underwent a spiral computed tomography (CT) scan, 99mTc-HYNIC annexin V tomography, and subsequent surgical resection of the suspected primary or recurrent tumor. Quantitative 99mTc-HYNIC annexin V uptake in tumor lesions divided by the tumor volume, derived from CT, was related to the number of apoptotic cells per tumor high-power field derived from terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end-labeling (TUNEL) assays performed on sectioned tumor slices. RESULTS: Diagnosis was primary head and neck tumor in 18 patients, lymph node involvement of a cancer of unknown primary origin in one patient, and the absence of recurrence in one patient. Mean percentage absolute tumor uptake of the injected dose per cubic centimeter tumor volume derived from tomographic images was 0.0003% (standard deviation [SD], 0.0004%) at 1 hour postinjection (PI) and 0.0001% (SD, 0.0000%) at 5 to 6 hours PI (P =.012). Quantitative 99mTc-HYNIC annexin V tumor uptake correlated well with the number of apoptotic cells if only tumor samples with no or minimal amounts of necrosis were considered. CONCLUSION: In the absence of necrosis, absolute 99mTc-HYNIC annexin V tumor uptake values correlate well with the number of apoptotic cells derived from TUNEL assays. 相似文献
62.
Floor A.M. Postema Jet Bliek Carel J.M. van Noesel Laura J.C.M. van Zutven Jan C. Oosterwijk Saskia M. J. Hopman Johannes H. M. Merks Raoul C. Hennekam 《Pediatric blood & cancer》2019,66(6)
Mosaic genome‐wide paternal uniparental disomy is an infrequently described disorder in which affected individuals have signs and symptoms that may resemble Beckwith–Wiedemann syndrome. In addition, they can develop multiple benign and malignant tumors throughout life. Routine molecular diagnostics may not detect the (characteristic) low level of mosaicism, and the diagnosis is likely to be missed. Genetic counseling and a life‐long alertness for the development of tumors is indicated. We describe the long diagnostic process of a patient who already had a tumor at birth and developed multiple tumors in childhood and adulthood. Furthermore, we offer clues to recognize the entity. 相似文献
63.
64.
65.
66.
67.
68.
69.
Ly-Thuy-Tram Le Morgane Couvet Bertrand Favier Jean-Luc Coll Chi-Hung Nguyen Annie Molla 《Oncotarget》2015,6(26):22152-22166
Aurora kinases play an essential role in mitotic progression and are attractive targets in cancer therapy. The first generation of benzo[e]pyridoindole exhibited powerful aurora kinase inhibition but their low solubility limited further development. Grafting a pyperidine-ethoxy group gives rise to a hydrosoluble inhibitor: compound C5M.C5M could efficiently inhibit the proliferation of cells from different origins. C5M prevented cell cycling, induced a strong mitotic arrest then, cells became polyploid and finally died. C5M did not impair the spindle checkpoint, the separation of the sister chromatids and the transfer of aurora B on the mid-zone. C5M prevented histone H3 phosphorylation at mitotic entry and erased AMPK-Thr172 phosphorylation in late mitosis. With this unique profile of inhibition, C5M could be useful for understanding the role of phospho-Thr172-AMPK, in abscission and the relationship between the chromosomal complex and the energy sensing machinery.C5M is a multikinase inhibitor with interesting preclinical characteristics: high hydro-solubility and a good stability in plasma. A single dose prevents the expansion of multicellular spheroids. C5M can safely be injected to mice and reduces significantly the development of xenograft. The next step will be to define the protocol of treatment and the cancer therapeutic field of this new anti-proliferative drug. 相似文献
70.